![](/cdn/assets/images/search/clock.png)
We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Share Name | Share Symbol | Market | Type | Share ISIN | Share Description |
---|---|---|---|---|---|
Valirx Plc | LSE:VAL | London | Ordinary Share | GB00BLH13C52 | ORD 0.1P |
Price Change | % Change | Share Price | Bid Price | Offer Price | High Price | Low Price | Open Price | Shares Traded | Last Trade | |
---|---|---|---|---|---|---|---|---|---|---|
0.00 | 0.00% | 2.40 | 2.30 | 2.50 | 2.40 | 2.40 | 2.40 | 203,011 | 08:00:00 |
Industry Sector | Turnover | Profit | EPS - Basic | PE Ratio | Market Cap |
---|---|---|---|---|---|
Medical Laboratories | 9k | -2.04M | -0.0154 | -1.56 | 3.18M |
Date | Subject | Author | Discuss |
---|---|---|---|
01/7/2024 12:08 | That’s why I quote rns word for word. George porky is on a mission to destroy suzy and valirx at all costs. He’s posted more than anyone by far yet is not invested. Dyor | ![]() jasonpugh | |
01/7/2024 11:56 | Jason, Whoever Porky is one has to accept that he is sometimes right. Treat his/her/its posts as contrarian if not in cink with your own views but use them to challenge one's own position where relevant. Try to avoid making or taking things personal. | ![]() carlisle44 | |
01/7/2024 10:00 | I won’t reply to you any longer porky George Morris. You sent me an email George some time ago regarding 201 patents. Your wording was perfect English as you forgot to put in your deliberate spelling mistakes (you were probably drunk ..this was what got you fired in the first place by sending that email). Porky your post on patents from a while ago is 90% same word structure as the private email George Morris sent me ! You are George as you both hate suzy with a vengeance. You have been rumbled. Dyor | ![]() jasonpugh | |
01/7/2024 09:29 | Jason - I’m not George. Just an investor. Ambrose don’t need to do anything, they don’t need to activate anything, have until 31/12 for exclusivity and could extend that if they need to or not. VAL are out of cash runway in a few weeks time, are you suggesting that £2m of cash is going to land shortly to stave off a placing or do you think SH will be asked to dig deep again? It’s cash today this business needs not Jam tomorrow updates- they won’t pay the bills will they? | ![]() porky9 | |
01/7/2024 08:14 | I’ll ask a third time. Will Ambrose activate the option before dec regarding the Val 401 based on Ambrose’s latest release. ???? Because when they do valirx will release an rns to confirm. Will this news increase the share price ?🤦 | ![]() jasonpugh | |
01/7/2024 08:11 | Jason: I really fail to see what you are excited about, other than a desperate attempt to pump the stock. Ambrose are simply doing what they said they were doing, ie further evaluation and development. They remain skint like most small start up bios. They have an option at the end of December this year to license 401. They could decline to license, extend the exclusivity period, license on milestones but no upfront payment, license on milestones with a £10k upfront payment who knows.That is there business but dev work is what they continue to do. Point is, VAL will be out of cash before they have to confirm what they are doing anyhow. Interesting that my post specifically about pumping this stock before a share issue and what happened the last two occasions where the stock was pumped and pre sold as a short book was opened plus the fact they had 71m of stock ready to issue was removed from LSE the weekend. Very unusual that. Someone really did not like it being highlighted how the game is being played here. I remain 100% convinced a discounted share issue placing will be required shortly if Adrian can secure support. Your question Jason is do you gamble you can get out on a spike before that happens? You have about a 10 -12 week window I recon.... | ![]() porky9 | |
01/7/2024 04:59 | Porky can’t read an rns. 🤦a Question. Will Ambrose active the option before dec this year based on the latest news from Ambrose the other day? I will answer the question. For Ambrose to release news about the new advisory board and publish their project pipeline. What interested me was they named the 401 as one of the two. The other undisclosed This tell me that Ambrose will 100% activate this option on Val 401. Porky George Morris. you can’t stop this happening | ![]() jasonpugh | |
01/7/2024 00:45 | Look Jason, you got suckered in on the recent spike, your underwater and due to the spread now need suckers to buy in at 3.5p for you to get out with money back. You keep pumping it sunshine. Good luck to you. The resolutions were recently passed for authorisation to issue 71m new shares, providing the discount is not greater than 80%. Now you can 100% trust me when I say this: those shares will be issued, providing he gets investor support they will be issued make no mistake. There are a few weeks of cash runway left, they still need to find a new chairman and CEO, nobody in their right mind is going to join a BOD without a clear 12 month runway ahead of them. Meanwhile, to jump on this Ambrose start up situation, is embarrassing, it’s a five year plan, if you think they are going to give VAL any cash this year you are seriously deluded, they don’t have any, they are raising cash to stay in business for own progress not to pay to keep VAL in business, VAL will need to raise its own cash. | ![]() porky9 | |
30/6/2024 08:02 | @porky aka George Morris. Your last post is misleading. A clarification is in order. Valirx rns dec 5th 2023 regarding Ambrose and 401. Para 3 “….Ambro Now with the latest news from Ambrose regarding 401. On page 11 it details the financial implications of a 4 year plan and the targeting of a five year plan. What porky fails to mention is the five year plan involves cash of £800 mill It clearly states on page 11 regarding 401. NPV of £70mill and peak revenues of £170mill. Go on investopefia and get the definition of NPV (net PRESENT value). Now reread valirx dec 5th 2023 rns. No five years here buddy. Only 12 months which expires in dec Do you think Ambrose are now wanting to execute the option with valirx ? Please DYOR. | ![]() jasonpugh | |
29/6/2024 21:51 | It’s on a 5 year dev program with Ambrose, let me repeat that 5 FIVE YEARS Back to removing posts again on LSE - shame What tipped it was not just me reminding that the placing was likely very soon, probably end of sept/ early october imo but I think it was the fact I reminded posters that they had just voted for resolutions at the AGM for the authority to issue 51million and 20million private new shares providing the discount was no more than 80% hence the placing a certain bet if Adrian secures support - someone didn’t like it anyhow. | ![]() porky9 | |
29/6/2024 18:02 | Interesting times. Rns dated 5th dec 2023 regarding Val 401 and Ambrose particularly with the press release from Ambrose just recently. 12 months up in dec. Also read what the below person says. Para 7. Toby Wilson waterworth ceo of Ambrose healthcare …. DYOR 👊 | ![]() jasonpugh | |
29/6/2024 10:51 | @Jason Your best outcome is a loss via dilution in the penny raise, your worst outcome is this going into administration. For you to get a profit, due to the spread, you need suckers to buy in at 3.5p. As for a new CEO joining, nobody in their right mind is going to take a ceo role here without a good 12 mph cash runway ahead of them, so most likely raise then ceo or ceo on condition of raise. | ![]() porky9 | |
29/6/2024 10:42 | Utter utter nonsense, there is at best 12-14 week cash runway left, a raise will come way way before any of those events, that’s if Adrian can secure support. £1.5m raise at 1p inbound end of September is my call. It is essential that he drains the swamp, Investors will NOT back more of the same | ![]() porky9 | |
29/6/2024 10:31 | the upside is more like 10000%! more good news on val401 or clx001 or both and this company will start trading at a 500mln pounds market cap. I had this success with another biotech, making me 3500%. | ![]() qnq | |
29/6/2024 10:28 | the upside is more like 10000%! more good news on val401 or clx001 or both and this company will start trading at a 500mln pounds market cap. I had this success with another biotech, making me 3500%. | ![]() qnq | |
29/6/2024 08:58 | On the law of probabilities. This year before placing required. 1. Funds from merger 201 2. Funds from lab (already started) 3. Ambrose and 401(yesterday’ 4. Clx001. This could surprise. Adam Hargreaves tweeted £20mill initially 5. 301. Could Theoremrx take this with 201 as a combined package? 6. New evaluations. 7. New ceo In conclusion no news on any of these this year is highly unlikely. DYOR I did mine and 3p with these possibilities are attractive. I may be wrong and loose 66% at 1p placing however if it rerates a possible 10bagger 30p as some have said (with suzy gone and new ceo). So in conclusion. A potential 66% loss or 900%profit. 🤔 | ![]() jasonpugh | |
29/6/2024 08:57 | Feb 9th"ValiRx plc (the "Company") (AIM: VAL), a life sciences company focusing on early-stage cancer therapeutics and women's health, announces that it has received a requisition notice from a shareholder group proposing certain changes to the Board."6 whole months later and we still have the same CEO drawing a £170,000 salary . I'm shocked that the large shareholders here are happy with this situation.We all know what happens if there is no change. Why is the CEO still there after 4 years of waiting for Theormx money when they have none ? | ![]() nico115 | |
28/6/2024 21:50 | Good luck Jason. You will need it, Jam tomorrow and none of it will pay for the BODs lifestyles today and the clock is ticking Either Adrian drains the swamp and sorts it or he doesn’t it’s that simple. I have put on record I will support the end of Sept/ early Oct raise if Adrian gets rid of Suzy and puts forward a compelling business plan going back to VALs original mission statement of looking to support early stage cancer cures Whilst we play at creating an imogen2 lab business with Suzy at the helm you can count me out | ![]() porky9 | |
28/6/2024 21:41 | Boy. Just read porkys take on Ambrose and 401. latest on lse. Wow. Wow. Wow. When funds hit for 201,401 what will it say? A packet of skittles to the winner. No favouritism George. Now now 👌. Ps I didn’t buy 300k for nothing matey 🥷 | ![]() jasonpugh | |
28/6/2024 19:21 | Something on lse regarding Ambrose. As I said 401 not dead it appears.good to DYOR. 👊 | ![]() jasonpugh | |
28/6/2024 13:18 | Rns dated dec 2023. Para “…… On another note read Ken’s cv on Theormrx website. Have you seen the companies he’s involved in? Over 1$ billion raised! Do you think 201 will happen? DYOR. | ![]() jasonpugh | |
28/6/2024 13:04 | Jason - unless you hold shares in EUDA it doesn’t matter if it’s share price rises bigger than Elon Musks empire, why would they want a two bit, potless additional cash drain on their books that would be an immediate liability when they can use their share price advantage to acquire more assets that are revenue producing. Talk about punters being sold a lemon by the VAL board, bloody hell, sooner Adrian wakes up and cuts this nonsense relationship the better | ![]() porky9 | |
28/6/2024 12:57 | @David Boomtime and @JasonPugh exchanges messages with each other reminds me of Tommy Cooper doing :Sally and the Sailor | ![]() porky9 | |
28/6/2024 12:22 | What’s euda looking like today pre ? 🌹💃 | ![]() david boomtime |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions